Radiation-Protective Agents
"Radiation-Protective Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. military, purposes.
Descriptor ID |
D011837
|
MeSH Number(s) |
D27.505.696.706.776 D27.720.799.763
|
Concept/Terms |
Radiation-Protective Agents- Radiation-Protective Agents
- Radiation Protectants
- Protectants, Radiation
- Radioprotective Drugs
- Drugs, Radioprotective
- Radiation-Protective Drugs
- Drugs, Radiation-Protective
- Radiation Protective Drugs
- Radioprotective Agents
- Agents, Radioprotective
- Agents, Radiation-Protective
- Agents, Radiation Protective
- Radiation Protective Agents
- Protective Agents, Radiation
Radiation-Protective Effect- Radiation-Protective Effect
- Effect, Radiation-Protective
- Radiation Protective Effect
- Radiation-Protective Effects
- Effects, Radiation-Protective
- Radiation Protective Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Protective Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Protective Agents".
This graph shows the total number of publications written about "Radiation-Protective Agents" by people in this website by year, and whether "Radiation-Protective Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 4 | 2 | 6 |
2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Radiation-Protective Agents" by people in Profiles.
-
A Radiation Mitigator as a Potential Treatment for COVID-19. Radiat Res. 2020 06 01; 193(6):505.
-
Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions. J Invest Dermatol. 2018 03; 138(3):490-499.
-
The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome. Sci Rep. 2017 12 11; 7(1):17355.
-
Prevention from radiation damage by natural products. Phytomedicine. 2018 Aug 01; 47:192-200.
-
Theaflavin ameliorates ionizing radiation-induced hematopoietic injury via the NRF2 pathway. Free Radic Biol Med. 2017 12; 113:59-70.
-
Microbial melanins for radioprotection and bioremediation. Microb Biotechnol. 2017 09; 10(5):1186-1190.
-
Melatonin and its metabolites protect human melanocytes against UVB-induced damage: Involvement of NRF2-mediated pathways. Sci Rep. 2017 04 28; 7(1):1274.
-
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis. Int J Mol Sci. 2017 Apr 17; 18(4).